About Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval Department of Urology #4
Clinical Trials at Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval Department of Urology #4
During the past decade, Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval Department of Urology #4 conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval Department of Urology #4"
#1 collaborator was "Nektar Therapeutics" with 1 trials as a collaborator and "Stada Arzneimittel AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval Department of Urology #4
According to Clinical.Site data, the most researched conditions in "Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval Department of Urology #4" are
"Multiple Sclerosis" (2 trials), "Carcinoma, Transitional Cell" (1 trials), "Macular Degeneration" (1 trials), "Muscle-invasive Bladder Cancer" (1 trials) and "Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval Department of Urology #4" in a lesser frequency.
Clinical Trials Intervention Types at Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval Department of Urology #4
Most popular intervention types in "Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval Department of Urology #4" are "Drug" (8 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (4 trials), "Placebo" (4 trials), "Adalimumab" (1 trials), "Carboplatin" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval Department of Urology #4
The vast majority of trials in "Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval Department of Urology #4" are
9 trials for "All" genders.
Clinical Trials Status at Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval Department of Urology #4
Currently, there are NaN active trials in "Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval Department of Urology #4".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval Department of Urology #4,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval Department of Urology #4, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".